Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Beluga NV | BELU | Nov 22, 2024 | 1.50 | 0.00 |
Belysse Group N.V. | BELYS | Nov 22, 2024 | 0.74 | -5.73 |
Biocartis Group NV | BCART | Nov 22, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | Nov 22, 2024 | 0.01 | +3.28 |
Biotalys | BTLS | Nov 22, 2024 | 2.99 | +1.70 |
Boeing | BOEI | Nov 22, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | Nov 22, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Nov 22, 2024 | 1.95 | +0.83 |
Brederode S.A. | BREB | Nov 22, 2024 | 105.80 | +0.76 |
Campine nv | CAMB | Nov 22, 2024 | 85.50 | +1.18 |
Candela Invest | CAND | Nov 22, 2024 | 1.20 | 0.00 |
Care Property Invest NV/SA | CPINV | Nov 22, 2024 | 12.30 | +1.82 |
Celyad Oncology SA | CYAD | Nov 22, 2024 | 0.65 | +0.15 |
Cenergy Holdings | CENER | Nov 22, 2024 | 8.44 | +1.56 |
Chevron | CHTEX | Nov 22, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | Nov 22, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | Nov 22, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | Nov 22, 2024 | 56.30 | +2.55 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | Nov 22, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | Nov 22, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | Nov 22, 2024 | 44.02 | -0.18 |
Compagnie du Bois Sauvage S.A. | COMB | Nov 22, 2024 | 221.00 | +2.79 |
Compagnie d`Entreprises CFE SA | CFEB | Nov 22, 2024 | 6.05 | +4.31 |
Connect Group | CONN | Nov 22, 2024 | 1.53 | 0.00 |
Crescent NV | OPTI | Nov 22, 2024 | 0.01 | -1.96 |
Cumulex NV | CLEX | Nov 22, 2024 | 1.35 | 0.00 |
CURETIS | CURE | Nov 22, 2024 | 0.29 | 0.00 |
Deceuninck NV. | DECB | Nov 22, 2024 | 2.42 | 0.00 |
Deme Group N.V. | DEME | Nov 22, 2024 | 146.80 | +2.51 |
Deutsche Telekom AG | DTEL | Nov 22, 2024 | 20.00 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.